Dhanuka Agritech Limited makes a corporate announcement

The Rs 70 Crores buyback terms were:

• Buyback price: Rs 1,400 per fully paid-up equity share.
• Method: Tender offer on a proportionate basis through the stock-exchange mechanism under SEBI’s buyback regulations—not an open-market buyback.
• Shares proposed to be bought back and extinguished: Up to 5,00,000 equity shares. ^[1]

The stated maximum consideration is therefore Rs 70 Crores.

The combined outflow is approximately Rs 78.92 crore, comprising the Rs 70 crore buyback plus an estimated Rs 8.92 crore dividend on the Q1 FY27-end share count. This is more than four times the company’s reported cash balance, but the balance sheet retains a much larger investment pool and very low debt.

Cash and net cash impact

Q1 FY27 standalone figures were:

• Cash and equivalents: Rs 18.93 crore ^[2]
• Investments: Rs 371.25 crore ^[3]
• Total debt: Rs 0.90 crore ^[4]
• Buyback: Rs 70 crore ^[1]
• Dividend: Rs 2 per share ^[5]

The Q1 FY27 paid-up equity capital was Rs 891.57 lakh at a Rs 2 face value, implying approximately 4.46 crore shares. Therefore, the dividend outflow is derived as:

`4.46 crore shares × Rs 2 = approximately Rs 8.92 crore` ^[6]

• Derived assuming the full buyback and dividend are settled from balance-sheet resources, with no intervening operating cash generation or investment liquidation.

Liquidity-ratio effect

The reported standalone current ratio was 4.09x, based on current assets of Rs 1,517.3 crore and current liabilities of Rs 370.59 crore ^{[7] [8] [9]}.

Mechanically, if the full Rs 78.92 crore were deducted from current assets and current liabilities were unchanged:

• Pro forma current assets: approximately Rs 1,438.38 crore
• Pro forma current ratio: approximately 3.88x
• Reduction: approximately 0.21x, or 5.10%

If the dividend were declared but remained unpaid, current liabilities would also rise by roughly Rs 8.92 crore; the mechanical current ratio would then be closer to 3.79x. However, the Rs 2 dividend was approved at the AGM after the June 30 quarter-end, so it is not reflected in the Q1 FY27 reported balance sheet ^[5].

Analytical implication: the distributions materially reduce immediately available cash, but do not create near-term balance-sheet stress on the reported figures because investments of Rs 371.25 crore substantially exceed the combined outflow and debt is only Rs 0.90 crore. The key caveat is that the broad post-distribution liquidity calculation treats all reported investments as available resources; the Q1 disclosures do not establish that every investment is cash-equivalent.*

Verdict: The Rs 70 Crores buyback is material, but it is smaller than Dhanuka Agritech’s two recent buybacks and does not, by itself, indicate a wholesale change in capital-allocation strategy. It is better interpreted as a recurring, flexible surplus-cash distribution mechanism alongside a structurally low regular dividend. The apparent shift toward shareholder returns in FY26 is partly explained by unusually low reported capex, while the announced Rs 200 Crores Nagpur plant shows that growth investment remains part of the strategy.

Five-year capital-allocation bridge

The payout ratio below is calculated as dividend attributable to the fiscal year divided by standalone PAT. FY22 and FY24 include both interim and final dividends; FY26 is based on the proposed final dividend and is therefore not yet a cash-paid figure.

Notes: † Derived as dividend divided by standalone PAT. ‡ Converted from amounts reported in Rs lakhs. The cited five-year series identifies buybacks in FY23, FY25 and FY26; blank buyback cells should not be read as a separately reported zero. FY22 capex is not included because no comparable figure is cited.

How large is Rs 70 Crores?

• Against recent buybacks: The FY26 buyback is 30% below the Rs 100 Crores FY25 buyback and 17.65% below the Rs 85 Crores FY23 buyback. Unlike FY23, when 10 lakh shares were repurchased, the latest transaction covers 5 lakh shares—the same number as the FY25 buyback. The lower cash outlay therefore reflects the lower offer price, not necessarily a smaller share-count reduction relative to FY25. ^{[14] [18] [19]}
• Against FY26 earnings: Rs 70 Crores equals approximately 24.37% of FY26 standalone PAT, versus approximately 33.67% for the Rs 100 Crores FY25 buyback and 36.40% for the Rs 85 Crores FY23 buyback. These are derived comparisons using the buyback amounts and the corresponding annual PAT figures. ^{[19] [18] [14] [12]}
• Against reserves: The latest buyback represents 4.20% of paid-up equity capital and free reserves, compared with 8.04% for the FY25 buyback. This is a more meaningful measure of balance-sheet intensity than the headline amount alone. ^{[20] [18]}
• Against investment: FY26 standalone capex of Rs 27.72 Crores was sharply below Rs 194.00 Crores in FY25. The Rs 70 Crores buyback was therefore approximately 2.53 times FY26 capex, but only about 36% of FY25 capex. ^{[15] [19]}

Does this represent a strategy change?

There is a change in emphasis, but not a fundamental change in policy. Dhanuka’s recent pattern is:

• periodic, relatively large buybacks in FY23, FY25 and FY26;
• low ordinary dividends in FY23, FY25 and FY26, with payout ratios around 3-4%;
• occasional higher dividend distributions, as seen in FY22 and FY24, when payout ratios were approximately 31% and 27%, respectively; and
• continued willingness to fund expansion when opportunities are available.

The company’s dividend policy explicitly allows retained earnings to be used either for business purposes or shareholder distributions, including buybacks, and lists capex, expansion, liquidity and surplus funds among the relevant decision factors. ^{[21] [21]} The FY26 board resolution similarly allowed the buyback to be funded from current surplus, cash balances, internal accruals or free reserves. ^[22]

The key implication is that buybacks are becoming a more visible supplementary route for returning surplus capital, rather than Dhanuka moving to a permanently high dividend-payout model. However, the Rs 200 Crores Nagpur formulation plant, targeted for operations by April 2028, indicates that management has not abandoned reinvestment in manufacturing capacity. ^[5] The FY26 buyback therefore looks more like an opportunistic distribution enabled by a low-capex year than evidence that shareholder returns have permanently displaced growth investment.